Pneumonia Testing Market in Asia Pacific is expected to register a CAGR of 10.5% during the forecast period (2018 - 2024) - KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Asia Pacific Pneumonia Testing Market, published by KBV research, the Asia Pacific Pneumonia Testing Market would witness market growth of 10.5% CAGR during the forecast period (2018 – 2024).

The Enzyme-Linked Immunosorbent Assay (ELISA) market dominated the Asia Pacific Pneumonia Testing Market by Technology 2017, thereby, achieving a market value of $135.6 million by 2024. The Immunofluorescence market is expected to witness a CAGR of 11.3% during (2018 - 2024). The Western Blot market is expected to witness a CAGR of 9.8% during (2018 - 2024). Additionally, The Immunohistochemistry (IHC) market is expected to witness highest CAGR of 13.5% during (2018 - 2024).

The Japan market would dominate the Asia Pacific Analyzers Pneumonia Testing Market by Country 2024;, growing at a CAGR of 7.8 % during the forecast period. The China market is expected to witness a CAGR of 11.1% during (2018 - 2024). Additionally, The India market is expected to witness a CAGR of 11.1% during (2018 - 2024).

The Diagnostic Centers market dominated the India Pneumonia Testing Market by End User 2017, growing at a CAGR of 10.5 % during the forecast period. The Hospitals market is expected to witness a CAGR of 11.9% during (2018 - 2024). Additionally, The Homecare market is expected to witness highest CAGR of 12.3% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/asia-pacific-pneumonia-testing-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Meridian Bioscience Inc., Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific.

Asia Pacific Pneumonia Testing Market Segmentation

By Method

  • Point-Of-Care (POC) Testing
  • Immunodiagnostics
  • Molecular Diagnostics

By End User

  • Diagnostic Centers
  • Hospitals
  • Homecare
  • Others

By Type

  • Analyzers
  • Consumables

By Technology

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunofluorescence
  • Western Blot,
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • Other Technology.

 By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Meridian Bioscience Inc.
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Thermo Fisher Scientific

Unique Offerings from KBV Research

  • Exhaustive coverage  
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Pneumonia Testing Market

North America Pneumonia Testing Market

Europe Pneumonia Testing Market

LAMEA Pneumonia Testing Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.